Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2

被引:26
|
作者
Mohr-Sasson, Aya [1 ,2 ]
Chayo, Jennifer [1 ,2 ]
Bart, Yossi [1 ,2 ]
Meyer, Raanan [1 ,2 ]
Sivan, Eyal [1 ,2 ]
Mazaki-Tovi, Shali [1 ,2 ]
Yinon, Yoav [1 ,2 ]
机构
[1] Sheba Med Ctr, Dept Obstet & Gynecol, IL-52621 Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
关键词
Pregnant women; Infection; COVID-19; SARS-CoV-2; Laboratory characteristics;
D O I
10.1007/s00404-020-05655-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Key message Laboratory characteristics of SARS-CoV-2 infection did not differ between pregnant and non-pregnant women. A trend of lower lymphocyte count was observed in the pregnant women group Purpose Laboratory abnormalities, which characterize SARS-CoV-2 infection have been identified, nevertheless, data concerning laboratory characteristics of pregnant women with SARS-CoV-2 are limited. The aim of this study is to evaluate the laboratory characteristics of pregnant compared to non-pregnant women with SARS-CoV-2 infection. Methods A retrospective cohort study of all pregnant women with SARS-CoV-2 who were examined at the obstetric emergency room in a tertiary medical center between March and April 2020. Patients were compared with non-pregnant women with SARS-CoV-2 matched by age, who were examined at the general emergency room during the study period. All patients were confirmed for SARS-CoV-2 on admission. Clinical characteristics and laboratory results were compared between the groups. Results Study group included 11 pregnant women with SARS-CoV-2, who were compared to 25 non-pregnant controls. Respiratory complaints were the most frequent reason for emergency room visit, and were reported in 54.5% and 80.0% of the pregnant and control groups, respectively (p = 0.12). White blood cells, hemoglobin, platelets, and liver enzymes counts were within the normal range in both groups. Lyphocytopenia was observed in 45.5% and 32% of the pregnant and control groups, respectively (p = 0.44). The relative lymphocyte count to WBC was significantly reduced in the pregnant group compared to the controls [13.6% (4.5-19.3) vs. 26.5% (15.7-29.9);p = 0.003]. C-reactive protein [20(5-41) vs. 14 (2-52) mg/dL;p = 0.81] levels were elevated in both groups but without significant difference between them. Conclusion Laboratory characteristics of SARS-CoV-2 infection did not differ between pregnant and non-pregnant women, although a trend of lower lymphocyte count was observed in the pregnant women group.
引用
收藏
页码:629 / 634
页数:6
相关论文
共 50 条
  • [31] SARS-CoV-2 Influence on Pregnant Women with Cardiovascular Diseases
    Barbu, Roxana Mihaela
    Pohaci-Antonesei, Luiza
    Stana, Bogdan
    Cojocaru, Cristian
    Pohaci-Antonesei, Catalin
    Cojocaru, Elena
    Gavrilescu, Cristina Maria
    Oprisa, Cristina
    2021 INTERNATIONAL CONFERENCE ON E-HEALTH AND BIOENGINEERING (EHB 2021), 9TH EDITION, 2021,
  • [32] Guidelines for pregnant women with suspected SARS-CoV-2 infection
    Favre, Guillaume
    Pomar, Leo
    Qi, Xiaolong
    Nielsen-Saines, Karin
    Musso, Didier
    Baud, David
    LANCET INFECTIOUS DISEASES, 2020, 20 (06): : 652 - 653
  • [33] SARS-CoV-2 variants and pregnant Women: A cause for Concern?
    Chionuma, Joy Onyinyechi
    Onyeaka, Helen
    Ekwebelem, Osmond C.
    Nnaji, Nnabueze Darlington
    VACCINE: X, 2022, 11
  • [34] SARS-CoV-2 infection in pregnant women and gestational losses
    Solorzano, M.
    Nadal, A.
    Bella Burgos, B.
    Arrieta Lergorburu, A.
    Lopez Sinues, I.
    Victoria Perez-Aranda, I.
    Hurtado Mas, S.
    Coloma Farre, B.
    Gonzalez Carreras, A.
    Ferreres Pinas, J.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S157 - S157
  • [35] SARS-CoV-2 in Pregnant Women: Consequences of Vertical Transmission
    Chaubey, Ishaan
    Vignesh, Ramachandran
    Babu, Hemalatha
    Wagoner, Isabelle
    Govindaraj, Sakthivel
    Velu, Vijayakumar
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [36] INSULIN DISAPPEARANCE RATE IN PREGNANT AND NON-PREGNANT WOMEN, AND IN NON-PREGNANT WOMEN GIVEN GHRIH
    LIND, T
    BELL, S
    GILMORE, E
    HUISJES, HJ
    SCHALLY, AV
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1977, 7 (01) : 47 - 51
  • [37] Evaluation of SARS-CoV-2 vaccination in pregnant and breastfeeding women
    Terezia, Harvanova
    Zuzana, Kobliskova
    Petr, Novak
    IJID REGIONS, 2023, 8 : 58 - 63
  • [38] Temporal Trend in SARS-CoV-2 Symptoms in Pregnant Women
    London, Viktoriya
    Blitz, Matthew J.
    Solmonovich, Rachel
    Silver, Michael
    Minkoff, Howard
    AMERICAN JOURNAL OF PERINATOLOGY, 2023, 40 (11) : 1259 - 1264
  • [39] Maternal and perinatal outcomes in pregnant women infected by SARS-CoV-2: A meta-analysis
    Bellos, Ioannis
    Pandita, Aakash
    Panza, Raffaella
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 256 : 194 - 204
  • [40] Affective cognition in response to infant stimuli in pregnant compared with non-pregnant women
    Bjertrup, Anne Juul
    Jahn, Frida Simon
    Hansen, Louise Schuett
    Miskowiak, Kamilla Woznica
    WOMEN & HEALTH, 2024, 64 (05) : 427 - 439